Author:
Tan Roderick J.,Chartoumpekis Dionysios V.,Rush Brittney M.,Zhou Dong,Fu Haiyan,Kensler Thomas W.,Liu Youhua
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Okusa, M. D. & Davenport, A. Reading between the (guide)lines--the KDIGO practice guideline on acute kidney injury in the individual patient. Kidney Int. 85, 39–48 (2014).
2. Johnson, S. A. & Spurney, R. F. Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy. Am. J. Physiol. Renal Physiol. 309, F807–F820 (2015).
3. Lambers Heerspink, H. J., de Borst, M. H., Bakker, S. J. & Navis, G. J. Improving the efficacy of RAAS blockade in patients with chronic kidney disease. Nat. Rev. Nephrol. 9, 112–121 (2013).
4. Fried, L. F. et al. Combined angiotensin inhibition for the treatment of diabetic nephropathy. N. Engl. J. Med. 369, 1892–1903 (2013).
5. Chartoumpekis, D. V. & Kensler, T. W. New player on an old field; the keap1/Nrf2 pathway as a target for treatment of type 2 diabetes and metabolic syndrome. Curr Diabetes Rev 9, 137–145 (2013).
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献